Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000902664-20-002335
Filing Date
2020-06-09
Accepted
2020-06-09 21:08:48
Documents
1
Period of Report
2020-06-04

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3149
  Complete submission text file 0000902664-20-002335.txt   4864
Mailing Address 4 PARK PLAZA SUITE 550 IRVINE CA 92614
Business Address 4 PARK PLAZA SUITE 550 IRVINE CA 92614 9494808300
ACACIA RESEARCH CORP (Reporting) CIK: 0000934549 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36754 | Film No.: 20953346
SIC: 6794 Patent Owners & Lessors

Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Issuer) CIK: 0001618835 (see all company filings)

EIN.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations